Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | IDO1 | P14902 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | CCKBR | P32239 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | HTR6 | P50406 | 4/20 | 0.38 |
| ▸ | TACR1 | P25103 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL838039 | 0.78 | MAPT (0.62) | MAPTIDO1SMN1; SMN2TP53GLA | |
| SCHEMBL836471 | 0.77 | MAPT (0.52) | MAPTIDO1SMN1; SMN2TP53GLA | |
| Necrostatin SCHEMBL856922 | 0.71 | RIPK1 (1.00) | MAPTIDO1SMN1; SMN2TP53GLA | |
| Necrostatin SCHEMBL29351522 | 0.71 | RIPK1 (1.00) | MAPTIDO1SMN1; SMN2TP53GLA | |
| Necrostatin SCHEMBL2030647 | 0.71 | RIPK1 (1.00) | MAPTIDO1SMN1; SMN2TP53GLA | |
| Necrostatin SCHEMBL14473477 | 0.71 | RIPK1 (1.00) | MAPTIDO1SMN1; SMN2TP53GLA | |
| SCHEMBL19197992 | 0.68 | MAPT (0.50) | MAPTIDO1SMN1; SMN2TP53GLA | |
| SCHEMBL21133080 | 0.66 | MAPT (0.61) | MAPTIDO1SMN1; SMN2TP53GLA | |
| SCHEMBL25368489 | 0.66 | MAPT (0.52) | MAPTIDO1SMN1; SMN2TP53GLA | |
| SCHEMBL25368484 | 0.66 | MAPT (0.52) | MAPTIDO1SMN1; SMN2TP53GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110159017-A1 | TRYTOPHAN CATABOLISM IN CANCER TREATMENT AND DIAGNOSIS | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. (US) | 2011-06-30 | — | — | US | claimed |
| WO-2010008427-A1 | TRYPTOPHAN CATABOLISM IN CANCER TREATMENT AND DIAGNOSIS | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. (US) | 2010-01-21 | — | — | WO | claimed |
| WO-2015187689-A1 | METHODS AND COMPOSITIONS TO STABILIZE DIFFERENT STEM CELL STATES | UNIVERSITY OF WASHINGTON - CENTER FOR COMMERCIALIZATION (US) | 2015-12-10 | — | — | WO | disclosed |
| US-20120277111-A1 | MicroRNA Mediated Neuronal Cell Induction | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2012-11-01 | — | — | US | disclosed |
| US-20110159017-A1 | TRYTOPHAN CATABOLISM IN CANCER TREATMENT AND DIAGNOSIS | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. (US) | 2011-06-30 | — | — | US | disclosed |
| WO-2010008427-A1 | TRYPTOPHAN CATABOLISM IN CANCER TREATMENT AND DIAGNOSIS | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. (US) | 2010-01-21 | — | — | WO | disclosed |